Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-16

FDA Approved: BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for the combination analgesic Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate (Actavis), confirming approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butalbital, Acetaminophen, Caffeine and Codeine Phosphate

Snippet

SUPPL AP for BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE (BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE)